The Treatment of Postmenopausal Osteoporosis

Abstract

Osteoporosis is an increasing public health problem, and the costs related to hip fractures alone are expected to double in North America and Europe in the next 25 years. The disorder is characterized by enhanced bone fragility, resulting in an increased risk of fractures, and is usually defined according to the reduction in bone mineral density. Early diagnosis is now possible with the use of precise methods for measuring bone density. Optimal management consists of maximizing peak bone mass in early adulthood and preventing the rapid bone loss that occurs soon after the menopause in all women and again much . . .